New pill for tough tumors enters human testing

NCT ID NCT04192344

Recruiting now Disease control Sponsor: Abbisko Therapeutics Co, Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tests an experimental pill called ABSK021 in people with advanced solid tumors (including a rare joint tumor called TGCT) who have run out of standard options. The main goal is to check safety and find the best dose, while also seeing if the drug can shrink tumors. About 276 participants will take the drug by mouth and be closely monitored.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Giant Cell Tumor of Tendon Sheath neoplasm tenosynovial giant cell tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASMS TENOSYNOVIAL GIANT CELL TUMOR

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Beijing Jishuitan Hospital
RECRUITING

Beijing, Beijing Municipality, China
Hebei Medical University Third Hospital
COMPLETED

Shijiazhuang, Hebei, China
Henan Cancer Hospital
ACTIVE_NOT_RECRUITING

Zhengzhou, Henan, China
Huashan Hospital of Fudan University
COMPLETED

Shanghai, Shanghai Municipality, China
Jiangsu Province Hospital
ACTIVE_NOT_RECRUITING

Nanjing, Jiangsu, China
Liaoning Cancer Hospital
COMPLETED

Shenyang, Liaoning, China
MD Anderson Cancer Center
COMPLETED

Houston, Texas, 77030, United States
Nanjing Drum Tower Hospital
ACTIVE_NOT_RECRUITING

Nanjing, Jiangsu, China
Precision NextGen Oncology
ACTIVE_NOT_RECRUITING

Beverly Hills, California, 90212, United States
SCRI at HealthOne
COMPLETED

Denver, Colorado, 80218-1238, United States
Shanghai Sixth People's Hospital
COMPLETED

Shanghai, Shanghai Municipality, China
The First Affiliated Hospital of Sun Yat-sen University
RECRUITING

Guangdong, Guangzhou, China
The First Affiliated Hospital of Zhengzhou Universtity
COMPLETED

Zhengzhou, Henan, China
The Second Affiliated Hospital Zhejiang University School of Medicine
RECRUITING

Hangzhou, Zhejiang, China
The Winship Cancer Institute of Emory University
COMPLETED

Atlanta, Georgia, 30322, United States
West China Hospital of Sichuan University
RECRUITING

Chengdu, Sichuan, China
Xi'an Hong Hui Hospital
RECRUITING

Xian, Shanxi, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.